<DOC>
	<DOCNO>NCT02018341</DOCNO>
	<brief_summary>A randomized double-blind placebo control homeopathic pathogenetic trial ( HPT ) carry 30 healthy adult volunteer . The remedy use proving administer potency 30C . The remedy use common homeopathic remedy commercially available US , exact remedy disclose participants.The purpose prove twofold : 1 ) determine difference symptom receive active versus placebo medicine , 2 ) see difference gene expression receive homeopathic remedy placebo . It hypothesize participant receive active medication symptom characteristic remedy specific pattern gene expression whole blood different placebo recipient . Participants record symptoms diary 3 day prior administration study medication , 3 day administration 3 day follow completion study medication . Blood drawn gene expression study day study medication start take study medication approximately 48 hour . An additional , optional blood draw possible future analysis gene expression do end study period .</brief_summary>
	<brief_title>The Homeogenomic Trial</brief_title>
	<detailed_description />
	<criteria>Read Speak English Acute illness last 7 day Chronic illness require daily medication Use homeopathic remedy within 4 week Use homeopathic remedy 200C potency past 2 month Women pregnant breastfeeding infant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Assessment biologic activity homeopathic remedy</keyword>
</DOC>